The establishment and rapid progress in sensitive biosensing using immunogold silver enhancement has occurred in the past 30 years. Its high sensitivity and simplicity have made immunogold silver enhancement a revolutionary technique for signal amplification in biosensing. This review focuses on the major applications of immunogold silver enhancement, with special emphasis on quantitative biosensing. In this review, the combinations of immunogold silver enhancement with a series of quantitative techniques, such as colorimetry, electrical and electrochemical methods, gravimetry, chemiluminescence, Raman spectroscopy, and inductively coupled plasma–mass spectrometry (ICP-MS), are discussed in detail. Immunogold silver enhancement has become one of the most useful methods in highly sensitive quantitative bioanalysis. The recent development of ICP-MS detection shows great potential in combination with immunogold silver enhancement.
Here, we report a new and facile method to prepare silver nanoparticles (Ag NPs) film for surface-enhanced Raman scattering (SERS)-based sensing. The porous Ni foam was used as a template to generate high quality of Ag NPs by seed-mediated growth of metallic nanoparticles. The preparation process is very economic and environment-friendly, can achieve the recovery of the raw materials. We found that the type of silver-plating solution and the growth time are two key factors to determine the magnitude of SERS signal enhancement. Using rhodamine 6G (R6G) and 4-animothiophenol (4-ATP) as probe molecules, the created Ag NP films exhibited relatively high enhancement ability, good stability, and well reproducibility. The synthesized SERS-active substrate was further used to detect melamine molecules, an illegal additive in infant milk powder, and the limitation of detection can reach 1μM
Hepatic Epstein-Barr virus-positive inflammatory follicular dendritic cell sarcoma (EBV+ IFDCS) represents a rare form of liver malignancy. The absence of distinct clinical and radiological characteristics, compounded by its rare occurrence, contributes to a challenging diagnosis. Here, we report a case of a 54-year-old Chinese female with a background of chronic hepatitis B virus treated with entecavir and complicated by advanced fibrosis presenting with a liver mass found on her annual surveillance ultrasound. Hepatectomy was performed under clinical suspicion of hepatocellular carcinoma. Immunomorphologic characteristics of the tumor were consistent with EBV+ IFDCS with distinct non-caseating granulomatous inflammation. Our case illustrates the importance of considering EBV+ IFDCS in the differential diagnosis of hepatic inflammatory lesions. Awareness of this entity and its characteristic features is essential for accurately diagnosing and managing this rare neoplasm.